This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Midday Movers: Pump Up the Volume

NEW YORK ( TheStreet) -- Several small-cap stocks were moving on above-average volume during Wednesday's session.

Speedus (SPDE) surged by $1.27, or 31.4%, to $5.31 after the company said its Zargis Medical subsidiary has been cleared as a developer for Apple's (AAPL) iPhone and has begun development of medical diagnostic support software and related peripherals for the device and other leading smartphones. Volume topped 954,000 shares, compared to the 50-day average daily volume of 190,000, according to the Nasdaq.

VeriChip (CHIP) jumped by 69 cents, or 37.1%, to $2.55 after the company said it has entered into a strategic partnership with the Diabetes Research Institute to develop a glucose-sensing RFID microchip, which "could potentially improve patient care and compliance among individuals with diabetes," the DRI said in a statement. Volume topped 6.3 million shares, compared to the 50-day average daily volume of 1.3 million, according to the Nasdaq.

Canada's Oilsands Quest (BQI) rose by 22 cents, or 17.5%, to $1.48 following comments from BP (BP) CEO Tony Hayward, who said the oil giant may increase its drilling position in Canada. "We have a modest position in Canada's oil sands. We can see if we can make it even bigger over time," Hayward told an industry conference in London, according to Dow Jones. Volume topped 11.4 million shares, compared to the 50-day average daily volume of 2.8 million, according to the Nasdaq.

MannKind (MNKD) climbed by 72 cents, or 14.2%, to $5.80 after boutique firm Griffon Securities initiated the stock with a buy rating and a price target of $26. The firm asserted that MannKind's Afresa inhalable treatment will change the way diabetes is treated. Volume topped 3.9 million shares, compared to the 50-day average daily volume of 1.8 million, according to the Nasdaq.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,055.38 +25.17 0.14%
S&P 500 2,091.35 +9.47 0.45%
NASDAQ 4,813.6510 +40.1790 0.84%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs